BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38635242)

  • 1. Estrogen-Only Hormone Therapy and Dementia.
    Glynne S
    JAMA; 2024 May; 331(18):1594. PubMed ID: 38635242
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen-Only Hormone Therapy and Dementia-Reply.
    Pourhadi N; Mørch LS; Meaidi A
    JAMA; 2024 May; 331(18):1594-1596. PubMed ID: 38635226
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen-Only Hormone Therapy and Dementia.
    Wood Alexander M; Einstein G; Rabin JS
    JAMA; 2024 May; 331(18):1593-1594. PubMed ID: 38635246
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks and benefits of hormone therapy after menopause for cognitive decline and dementia: A conceptual review.
    Rocca WA; Kantarci K; Faubion SS
    Maturitas; 2024 Jun; 184():108003. PubMed ID: 38649310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes after menopause: influence of estrogen.
    Henderson VW
    Clin Obstet Gynecol; 2008 Sep; 51(3):618-26. PubMed ID: 18677155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coronary artery disease and menopausal hormone therapy].
    Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
    Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
    [No Abstract]   [Full Text] [Related]  

  • 9. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
    Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction: menopausal hormone therapy: where are we today?
    Cedars MI
    Fertil Steril; 2014 Apr; 101(4):885-6. PubMed ID: 24613540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen replacement therapy and asthma.
    Ticconi C; Pietropolli A; Piccione E
    Pulm Pharmacol Ther; 2013 Dec; 26(6):617-23. PubMed ID: 24035822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
    Popat RA; Van Den Eeden SK; Tanner CM; McGuire V; Bernstein AL; Bloch DA; Leimpeter A; Nelson LM
    Neurology; 2005 Aug; 65(3):383-90. PubMed ID: 16087902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications and controindications of hormone replacement therapy in menopause].
    Fichera M; Rinaldi N; Tarascio M; Taschetta S; Caldaci LM; Catavorello A; La Rosa B; Panella MM
    Minerva Ginecol; 2013 Jun; 65(3):331-44. PubMed ID: 23689177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].
    Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF
    Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous hormone replacement therapy.
    Tzingounis VA; Perdikaris AG; Lioutas G; Dimopoulos D
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):64-6. PubMed ID: 8365523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.